Clinical trials
Withdrawn Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 10 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 3 |
| Cerecin | 3 |
| Johns Hopkins University | 3 |
| Massachusetts General Hospital | 3 |
| Wake Forest University Health Sciences | 3 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Emory University | 2 |
| GlaxoSmithKline | 2 |
| Medical College of Wisconsin | 2 |
| Northwestern University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 96 |
| Dementia | 26 |
| Cognitive Dysfunction | 21 |
| Neurodegenerative Diseases | 5 |
| Anxiety Disorders | 4 |
| Brain Diseases | 4 |
| Memory Disorders | 4 |
| Amyloidosis | 3 |
| Amyloid Neuropathies, Familial | 2 |
| Amyloidosis, Familial | 2 |
Trials
Showing 51 to 75 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.